File(s) under permanent embargo

Reason: Restricted by author. A copy can be supplied under Section 51(2) of the Australian Copyright Act 1968 by submitting a document delivery request through your library, or by emailing document.delivery@monash.edu

Discovery & Design of Novel DsbA Inhibitors Using Fragment-Based Design Strategies

thesis
posted on 18.02.2020, 06:27 by WESAM SHALAN ALWAN ALWAN
In this work, Wesam designed and synthesised compounds to overcome multi-drug resistant bacteria and potentially protect future antibiotics from becoming obsolete. This was done by investigating a novel mechanism of disarming bacteria thereby making them unable to cause infections, rather than killing bacteria. The project focussed on using fragment-based drug design to develop inhibitors of a bacterial protein that is a master regulator of bacterial virulence.

History

Campus location

Australia

Principal supervisor

Martin J Scanlon

Additional supervisor 1

Ben Capuano

Additional supervisor 2

Bradley Doak

Year of Award

2020

Department, School or Centre

Medicinal Chemistry

Course

Doctor of Philosophy

Degree Type

DOCTORATE

Usage metrics

Exports